Atlas Trials

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects

Clinical trial NCT07324434 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07324434
Sponsor
Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.
Status
ENROLLING_BY_INVITATION
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperuricemia With or Without Gout
Start date
2025-12-15
Primary completion
2026-10-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.